Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly one-hour infusion of kahalalide F in NSCLC after first-line chemotherapy
2004-001253-29Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Sep 2004
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of kahalalide f in non-small cell lung cancer (NSCLC), sponsored by PharmaMar. Primary endpoint: Objective Response. Started Sep 2004; status: completed.
02
Drugs
kahalalide f
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2004-001253-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001253-29.